trial
as of 2026-07-01Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia
NCTId NCT03304457
at a glance
Phase 4 · Completed
Enrollment 100 (actual)
Sponsored by All India Institute of Medical Sciences, Bhubaneswar
Primary completion 2018-03-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
100 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2017-08-25
Primary completion
2018-03-12
Eligibility
ALL · 18 Years · 45 Years
Interventions & indications
Sponsors
Investigators
1
Debasish Hota, MD, DMStudy Director
Sites
1 total
Bhubaneswar, India
Facts & assertions
4 sourced
Enrollment
100
Phase
PHASE4
Primary Completion Date
2018-03-12
Status
COMPLETED
relationships
The graph out of here
drug
drug
drug
lead_sponsor
indication
indication
indication
investigator
person